"Interferon-gamma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.
| Descriptor ID |
D007371
|
| MeSH Number(s) |
D12.644.276.374.440.893 D12.644.276.374.480.615.350 D12.776.467.374.440.893 D12.776.467.374.480.615.350 D23.529.374.440.893 D23.529.374.480.615.350
|
| Concept/Terms |
Interferon-gamma- Interferon-gamma
- gamma-Interferon
- Interferon, Immune
- Immune Interferon
- Type II Interferon
- Interferon, Type II
- Interferon Type II
- Interferon, gamma
|
Below are MeSH descriptors whose meaning is more general than "Interferon-gamma".
Below are MeSH descriptors whose meaning is more specific than "Interferon-gamma".
This graph shows the total number of publications written about "Interferon-gamma" by people in this website by year, and whether "Interferon-gamma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 5 | 6 |
| 1997 | 6 | 4 | 10 |
| 1998 | 3 | 1 | 4 |
| 1999 | 1 | 6 | 7 |
| 2000 | 0 | 3 | 3 |
| 2001 | 1 | 6 | 7 |
| 2002 | 5 | 10 | 15 |
| 2003 | 0 | 11 | 11 |
| 2004 | 8 | 5 | 13 |
| 2005 | 1 | 9 | 10 |
| 2006 | 7 | 14 | 21 |
| 2007 | 4 | 10 | 14 |
| 2008 | 7 | 7 | 14 |
| 2009 | 3 | 10 | 13 |
| 2010 | 2 | 14 | 16 |
| 2011 | 11 | 5 | 16 |
| 2012 | 1 | 16 | 17 |
| 2013 | 2 | 11 | 13 |
| 2014 | 4 | 6 | 10 |
| 2015 | 6 | 5 | 11 |
| 2016 | 3 | 8 | 11 |
| 2017 | 2 | 10 | 12 |
| 2018 | 0 | 12 | 12 |
| 2019 | 3 | 4 | 7 |
| 2020 | 4 | 9 | 13 |
| 2021 | 0 | 4 | 4 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 2 | 2 |
| 2024 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interferon-gamma" by people in Profiles.
-
HIF1a-regulated glycolysis promotes activation-induced cell death and IFN-? induction in hypoxic T cells. Nat Commun. 2024 10 30; 15(1):9394.
-
BST2 facilitates activation of hematopoietic stem cells through ERK signaling. Exp Hematol. 2024 Dec; 140:104653.
-
LAG-3 and PD-1 synergize on CD8+ T?cells to drive T cell exhaustion and hinder autocrine IFN-?-dependent anti-tumor immunity. Cell. 2024 Aug 08; 187(16):4355-4372.e22.
-
Ectoine Enhances Mucin Production Via Restoring IL-13/IFN-? Balance in a Murine Dry Eye Model. Invest Ophthalmol Vis Sci. 2024 Jun 03; 65(6):39.
-
Leishmania donovani mitogen-activated protein kinases as a host-parasite interaction interface. Cytokine. 2024 07; 179:156627.
-
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
-
IFN-? and CD38 in AML: a T-cell engagement made in heaven? Blood. 2024 04 18; 143(16):1556-1557.
-
Comprehensive characterization of IFN? signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nat Commun. 2024 Feb 28; 15(1):1821.
-
Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani. Cytokine. 2024 02; 174:156475.
-
SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8+ T cells. Sci Transl Med. 2023 09 13; 15(713):eade2581.